Search again:
…for new methods to achieve long term transplant survival. T regulatory (Treg) cells have great potential to protect islet grafts from rejection. Treg cells are a subset of white blood…
…the estrogen, progesterone, and HER2 receptors targeted by many traditional chemotherapeutic drugs. Moreover, the tumours readily develop resistance to new generation chemotherapeutic agents, such as Iressa. Further studies are desperately…
…by our strategy to build talent, catalyze change for a stronger health research system, and mobilize communities for research impact. Led by our chief scientific officer, Dr. Stirling Bryan, and…
…Mycobacterium tuberculosis, the bacteria that causes TB. Approximately two million people die of TB annually, and about eight million new cases arise each year. In addition to the emergence of…
…partners, and the provincial government,” says Dr. Bev Holmes, MSFHR’s president & CEO, whose appointment was announced at the event. “It’s a time of great opportunity for health research and…
…of damaged regions after stroke – effectively rewiring the brain for function. However, the way that brain cells change their activity after stroke, and how these changes affect recovery, is…
Please welcome Roger Francis as our new vice-president, external relations. Michael Smith Health Research BC welcomes Roger Francis as our vice-president, external relations, effective immediately. In this newly created role,…
…blood vessels. An important piece of this research is to develop a more complete understanding of how cancer cells “hijack” blood vessels to induce this process. Dr. Alexandre Patenaude’s research…
…the burden of chronic tendon pain. Normal tendon is composed of rope-like molecules (type I collagen). In contrast, in tendinopathy the collagen can become spongey – like in cartilage (type…
In 2006, it was estimated that 153,100 new cancer cases were diagnosed in Canada, and 70,400 patients died of cancer. Improving our understanding of the molecular changes in cancer development…